In 2017, Allergan CEO Brent Saunders promised to reign in drug price hikes, and other Pharma companies followed suit. In 2021, it looks like all bets are off. In August, Amgen raised the price of its psoriasis med Otezla by 2.4 percent after raising the price of its oncology biologic Mvasi and chronic kidney disease
Questions about pharma pricing and marketing originally appeared in KevinMD.com.
